相关实验视频

Updated: Sep 12, 2025

Establishment and Characterization of Three Afatinib-resistant Lung Adenocarcinoma PC-9 Cell Lines Developed with Increasing Doses of Afatinib

Establishment and Characterization of Three Afatinib-resistant Lung Adenocarcinoma PC-9 Cell Lines Developed with Increasing Doses of Afatinib

Published on: June 26, 2019

索拉费尼布治疗的Th9细胞在肺转移中表现出优异的抗瘤作用

Fanli Yuan¹, Hanliang Wang^2,3, Shuowang Wang³

¹Clinical Laboratory, Affiliated Xiangshan Hospital of Wenzhou Medical University, Ningbo, 315700, Zhejiang, China.

Scientific reports

|August 7, 2025

概括

索拉芬尼增强了用于采用细胞治疗的T辅助9 (Th9) 细胞扩张. 这些扩展的Th9细胞通过调节瘤免疫微环境,显示出对肺转移的改善抗瘤作用.

科学领域:

免疫学免疫学免疫学
在瘤学瘤学.
细胞疗法细胞疗法

背景情况:

肺转移是一个重要的临床挑战,治疗策略有限.
辅助性T9 (Th9) 细胞表现出强大的抗瘤活性,超过了Th1和Th17细胞.
适用于采用细胞疗法 (ACT) 的Th9细胞的有效体外扩张尚不清楚.

研究的目的:

研究有效的Th9细胞体外扩张的方法.
评估Sorafenib治疗的Th9细胞对肺转移的治疗潜力.

主要方法:

使用Sorafenib (Sora) 来增强Th9细胞的增殖在体外.
研究了ERK信号在Sora介导的Th9细胞扩张中的作用.
在肺转移小鼠模型中评估Sora治疗的Th9细胞的抗瘤疗效.

主要成果:

索拉芬尼在体外通过ERK信号传递显著提高了Th9细胞扩张的效率.
索拉治疗的Th9细胞在体内表现出增强的抗瘤作用.
在肺转移模型中,Th9细胞疗法重塑了瘤免疫微环境.

结论:

索拉芬尼为扩大Th9细胞提供了一种可行的方法,用于潜在的肺转移治疗.
这种方法对推进肺癌转移的采用细胞治疗策略具有前途.

关键词:

埃尔克·埃尔克是什么意思肺部转移肺部转移肺部转移索拉费尼布 (Sorafenib) 是一种在Th9细胞中.瘤免疫系统的免疫力

更多相关视频

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis

Published on: September 12, 2019

Experimental Metastasis and CTL Adoptive Transfer Immunotherapy Mouse Model

Experimental Metastasis and CTL Adoptive Transfer Immunotherapy Mouse Model

Published on: November 26, 2010

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...